Evotec SE (EVO) EBIAT (2020 - 2026)
Evotec SE's (EVO) quarterly EBIAT came in at -$142756.0 in Q1 2026, down 329.79% year-on-year from $62124.8 in Q1 2025, and up 99.88% quarter-over-quarter from -$120.4 million in Q4 2025.
Evotec SE (EVO) EBIAT (2020 - 2026) Analysis & Trends
Evotec SE has disclosed EBIAT across 7 years of filings, most recently posting -$142756.0 for Q1 2026.
- EBIAT for Q1 2026 came in at -$142756.0, down 329.79% year-over-year; the trailing twelve-month figure through Mar 2026 was -$120.6 million (up 42.44% YoY), and the FY2025 annual result was -$120.5 million, up 42.49% from the prior year.
- EBIAT came in at -$142756.0 for Q1 2026 at Evotec SE, up from -$120.4 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $47666.2 in Q3 2022 to a low of -$209.4 million in Q4 2024.
- The 5-year median for EBIAT is -$49215.3 (2025), against an average of -$35.3 million.
- Across the five-year window, EBIAT jumped 118.15% in 2023 and tumbled 528.86% in 2024, its largest moves.
- Evotec SE's EBIAT stood at -$179.4 million in 2022, then soared by 49.7% to -$90.2 million in 2023, then plunged by 132.08% to -$209.4 million in 2024, then soared by 42.51% to -$120.4 million in 2025, then soared by 99.88% to -$142756.0 in 2026.
- The last three EBIAT figures came in at -$142756.0 (Q1 2026), -$120.4 million (Q4 2025), and -$50371.1 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 369.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.36 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 16.20 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | -142,756.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -142,756.04 |
| Dec 31, 2025 | -120.36 Mn |
| Sep 30, 2025 | -50,371.08 |
| Jun 30, 2025 | -49,215.34 |
| Mar 31, 2025 | -33,215.35 |
| Dec 31, 2024 | -209.36 Mn |
| Sep 30, 2024 | -43,526.83 |
| Jun 30, 2024 | -102,231.09 |
| Mar 31, 2024 | -22,458.36 |
| Dec 31, 2023 | -90.21 Mn |
| Sep 30, 2023 | 42,406.04 |
| Jun 30, 2023 | -16,256.55 |
| Mar 31, 2023 | 14,917.30 |
| Dec 31, 2022 | -179.36 Mn |
| Sep 30, 2022 | 47,666.17 |
| Jun 30, 2022 | -29,810.36 |
| Mar 31, 2022 | -82,202.26 |
| Dec 31, 2021 | 246.25 Mn |
| Sep 30, 2021 | 158,344.09 |
| Jun 30, 2021 | 72,274.35 |